Twin Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-21,342
Closed -$3.33M 313
2020
Q4
$3.33M Sell
21,342
-1,500
-7% -$234K 0.3% 103
2020
Q3
$2.61M Sell
22,842
-1,145
-5% -$131K 0.24% 123
2020
Q2
$2.69M Sell
23,987
-1,949
-8% -$219K 0.26% 122
2020
Q1
$2.33M Buy
25,936
+1,110
+4% +$99.7K 0.25% 125
2019
Q4
$2.69M Sell
24,826
-4,810
-16% -$520K 0.23% 139
2019
Q3
$2.9M Sell
29,636
-1,564
-5% -$153K 0.21% 148
2019
Q2
$4.09M Sell
31,200
-15,970
-34% -$2.09M 0.28% 121
2019
Q1
$6.38M Buy
47,170
+80
+0.2% +$10.8K 0.31% 99
2018
Q4
$4.59M Buy
47,090
+41,708
+775% +$4.06M 0.26% 120
2018
Q3
$748K Buy
+5,382
New +$748K 0.03% 286
2018
Q2
Sell
-8,375
Closed -$933K 368
2018
Q1
$933K Sell
8,375
-30,411
-78% -$3.39M 0.05% 277
2017
Q4
$4.64M Buy
38,786
+8,136
+27% +$973K 0.23% 127
2017
Q3
$4.3M Buy
30,650
+4,640
+18% +$651K 0.23% 129
2017
Q2
$3.17M Buy
26,010
+2,090
+9% +$254K 0.19% 166
2017
Q1
$2.9M Sell
23,920
-180
-0.7% -$21.8K 0.18% 174
2016
Q4
$2.95M Buy
24,100
+320
+1% +$39.2K 0.19% 162
2016
Q3
$2.91M Buy
23,780
+5,390
+29% +$660K 0.2% 161
2016
Q2
$2.15M Sell
18,390
-1,600
-8% -$187K 0.16% 163
2016
Q1
$2.78M Buy
19,990
+680
+4% +$94.7K 0.22% 139
2015
Q4
$3.68M Buy
19,310
+2,550
+15% +$486K 0.3% 100
2015
Q3
$2.62M Buy
16,760
+470
+3% +$73.5K 0.25% 127
2015
Q2
$2.95M Sell
16,290
-5,420
-25% -$980K 0.26% 122
2015
Q1
$3.76M Buy
21,710
+2,270
+12% +$393K 0.33% 97
2014
Q4
$3.6M Buy
19,440
+5,960
+44% +$1.1M 0.34% 90
2014
Q3
$2.24M Buy
+13,480
New +$2.24M 0.23% 135